- Report
- July 2022
- 40 Pages
China
From €2495EUR$2,595USD£2,141GBP
- Report
- July 2022
- 40 Pages
Brazil
From €2495EUR$2,595USD£2,141GBP
- Report
- November 2021
- 747 Pages
Global
From €3846EUR$4,000USD£3,299GBP
- Report
- November 2021
- 392 Pages
Global
From €2885EUR$3,000USD£2,475GBP
- Report
- November 2021
- 280 Pages
Global
From €2692EUR$2,800USD£2,310GBP
- Report
- December 2021
- 190 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- March 2021
- 198 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- October 2020
- 219 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- March 2020
- 201 Pages
Global
From €5163EUR$5,370USD£4,430GBP
- Report
- September 2019
Global
From €5163EUR$5,370USD£4,430GBP
- Report
- February 2024
- 140 Pages
Global
From €5288EUR$5,499USD£4,536GBP
- Report
- May 2022
- 210 Pages
Global
From €5547EUR$5,769USD£4,759GBP
- Book
- February 2023
- 576 Pages
- Book
- December 2019
- 312 Pages
- Book
- October 2018
- 528 Pages
The Drug Eluting market is a subset of the Medical Devices industry. It is focused on the development and production of drug-eluting devices, which are used to deliver drugs to specific areas of the body. These devices are designed to provide a controlled and sustained release of drugs over a period of time, allowing for more effective treatment of a variety of medical conditions. Drug-eluting devices are used in a variety of medical applications, including cardiovascular, orthopedic, and oncology treatments.
The Drug Eluting market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Medtronic, Abbott, Boston Scientific, Johnson & Johnson, and Stryker. Show Less Read more
